For Which Cancer Types Should I Avoid Skullcap Supplement?

Highlights

Nutritional supplements and extracts like Skullcap have benefits and are used by cancer patients and those at-genetic risk of cancer. There is limited or hardly any clinical data available for use of nutritional supplements and foods in cancer patients. Generating clinical evidence of efficacy for cancer through a randomized clinical trial is further infeasible due to variations in genetics and cancer chemotherapy treatments across cancer patients. Hence a different and new approach is needed to find out for which cancers you should not take Skullcap supplement and why should not take them?

Is it okay to take Skullcap extracts or supplements for all cancer indications and any chemotherapy treatment? A common belief but a myth is that everything natural can only be of benefit and do no harm. For example, the use of grapefruit with certain medications is not recommended. Another example is the use of spinach with some blood thinning medications can cause adverse interactions and hence to be avoided. For cancer, nutrition including plant-based foods and supplements can influence outcomes and hence an extremely important decision which needs to be made. Hence NIH-National Cancer Institute has a website for nutrition for cancer care for patients which are generalized recommendations and not personalized for cancer indication and treatments.

A frequently asked question by cancer patients and those at-risk is “What Foods and Nutritional Supplements could be beneficial over others for me?”. “Who should not take an extract or supplement and why?”. Generic guidelines like eating only plant-based-foods or avoiding all sugar or adopting a keto diet is a good start but not actionable and personalized enough.

To find answers to questions on extracts and nutritional supplements and foods requires knowledge of contained active ingredients; genetic mutation prevalence for cancer indication; understanding of underlying cancer biology; chemotherapy treatments and mechanism of actions of active ingredients.

Taking Skullcap extracts or nutritional supplements may benefit Primary Penile Squamous Cell Carcinoma patients on Cisplatin treatment over Mint nutritional supplements. But Skullcap supplements or Skullcap extracts offer less benefit if on Doxorubicin treatment for Primary Non-Hodgkin Lymphoma compared to Reishi Mushroom. Similarly, taking nutritional supplements Skullcap may benefit healthy individuals who are at genetic risk of cancer due to mutation of gene MLH1 over Astragalus. But avoid nutritional supplements Skullcap when at genetic risk of cancer due to mutation of gene ASXL1.

The takeaway being – cancer, genomics, treatments and other personalized factors will influence decision making to questions like: Are extracts or nutritional supplements Skullcap beneficial and should not be taken? Why should Skullcap be not taken? Who should not take Skullcap? What are side effects of Skullcap with Doxorubicin chemotherapy? What are the benefits of Skullcap for cancer? Can Skullcap help fight cancer and so on.

Whenever there are changes in chemotherapy treatments or cancer tissue genetics – the nutrition may change and hence needs to be re-evaluated. Do consider factors like cancer indication, ongoing chemotherapy treatments and nutritional supplements, age, gender, weight, height, lifestyle and genetics for personalization of nutrition.

Brief Overview

Use of nutritional supplements – vitamins, herbs, minerals, probiotics, and other specialty categories are increasing. Supplements are high concentrations of active ingredients which are also found in different foods. Difference between supplements and foods being that foods contain more than one active ingredient at much lower concentrations. Every active ingredient in an extract or nutritional supplement or food has a unique mechanism of action which can influence nutrition decisions.

These are some example questions which nutrition planning should help answer for you. Should you take supplements Skullcap? Should you take it when at genetic risk of cancer for mutation of gene MLH1? Should you take it when at genetic risk of cancer for mutation of gene ASXL1? Should you take it when diagnosed with Primary Non-Hodgkin Lymphoma? Should you take it when diagnosed with Primary Penile Squamous Cell Carcinoma? Should you take it when on Cisplatin treatment? Should you continue taking it if you change your treatment from Cisplatin to Doxorubicin? So a general explanation like – it is organic and plant-based or it increases immunity is not sufficient information for making a decision of use of Skullcap extracts and nutritional supplements.

Cancer

Genetic variations across cancer patients can be different and hence no two cancers are alike. The improved availability of “personalized to genetics” chemotherapy treatments and cancer disease monitoring via blood and saliva have been significant factors to improve outcomes. The earlier the lifestyle and treatment intervention – the better the influence on outcome. Genetic testing has the potential to assess cancer risk and susceptibility early. But for at-risk individuals besides regular monitoring in most cases there are no therapeutic treatment intervention options available. After diagnosis with cancer such as Primary Penile Squamous Cell Carcinoma or Primary Non-Hodgkin Lymphoma, the treatments get personalized to tumor genomics and factors like staging of disease, age and gender. During cancer remission (after treatment cycle is complete) – monitoring is used for assessment of any relapse and accordingly decide on next steps. A large majority of cancer patients and those at-risk may take nutritional supplements like Skullcap.

So the question is that are all genetic risks and cancer indications to be considered uniformly when making decisions on the use of Skullcap extracts or nutritional supplements? Are the biochemical pathway implications of genetic risk for cancer due to mutation of gene MLH1 the same as due to mutation of gene ASXL1? Are the implications of Primary Penile Squamous Cell Carcinoma the same as Primary Non-Hodgkin Lymphoma? Is it one and the same if you are on treatment with Doxorubicin or Cisplatin?

Skullcap – An Extract or Nutritional Supplement

Skullcap belongs to the mint family. There are two varieties of skullcap – American and Chinese. The name is derived from scutella which means “little dish”. The American variety of Skullcap leaves have been traditionally used as sedatives. The roots of Skullcap are also used as supplements. Following are some of the potential benefits of skullcap:

• Enhances mood by reducing anxiety (Christine Brock et al, Phytother Res., 2014) 
• Has antibacterial and antiviral properties (Qing Zhao et al, Sci Bull (Beijing)., 2016)
• Protects against heart disease like myocardial infarction (Mukesh Kumar et al, Inflamm Res., 2016)
• Has anticancer properties (Adrienne C Scheck et al, BMC Complement Altern Med. 2006)
• Has Anti-oxidant and anti-inflammatory effect. (Z Gao et al, Biochim Biophys Acta., 1999; Mukesh Kumar et al, Inflamm Res., 2016)

Skullcap supplements contain many active ingredients including Wogonin and Baicalein at different concentration levels. The molecular pathways which are regulated by Skullcap include Epithelial to Mesenchymal Transition, Oncogenic Cancer Epigenetics and Chromatin Remodeling. These biochemical pathways directly or indirectly regulate specific cancer molecular endpoints like growth, spread and death of cancer cells. Because of this biological regulation – for cancer nutrition, the right choice of supplements like Skullcap individually or in combination is an important decision to be made. When making decisions on the use of supplement Skullcap over other nutritional supplements – do consider all these factors.

Who Should not take Skullcap Supplements and Why?

There is no easy way to answer the question “For which cancers should I not chooseSkullcap nutritional supplements”. Just like the same chemotherapy treatment does not work across patients, for similar reasons Skullcap in comparison with other nutritional supplements may be beneficial or not. Along with which cancer and associated genetics – the ongoing treatments, lifestyle habits, height, weight and food allergies are all factors in deciding if Skullcap should be avoided or not and why.

1. Will Skullcap Supplements benefit Primary Non-Hodgkin Lymphoma patients undergoing Doxorubicin treatment?

Primary Non-Hodgkin Lymphoma is characterized and driven by specific genetic mutations like TET2, RHOA and CDK12 leading to biochemical pathway changes in Oncogenic Cancer Epigenetics, Cytoskeletal Dynamics and Adherens junction. A cancer treatment like Doxorubicin works through a specific pathway mechanism of action. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach which is effective. In such a condition any food or nutritional supplement which has a contrary effect to the treatment or reduces the overlap should be avoided. As an example, Skullcap supplement should not be taken for Primary Non-Hodgkin Lymphoma along with treatment Doxorubicin. Skullcap supplement impacts the biochemical pathway called Oncogenic Cancer Epigenetics which either promotes drivers of the disease and/or nullifies the treatment effect. Some of the factors which should be considered when choosing nutrition are type of cancer, treatments and supplements being taken currently (if any

2. Will Skullcap Supplements benefit Primary Penile Squamous Cell Carcinoma Patients undergoing Cisplatin Treatment?

Primary Penile Squamous Cell Carcinoma is characterized and driven by specific genetic mutations like ABRAXAS1, PIK3CB and NUP93 leading to biochemical pathway changes in Epithelial to Mesenchymal Transition, Hematopoiesis and Inositol Phosphate Signaling. A cancer treatment like Cisplatin works through specific pathway mechanisms. The goal is to have a good overlap between the treatment and cancer driving pathways for a personalized approach. In such a condition any food or nutritional supplement which supports treatment action or improves the overlap should be considered. As an example, Skullcap supplements should be considered for Primary Penile Squamous Cell Carcinoma along with the treatment Cisplatin. Skullcap supplement impacts pathways/processes like Epithelial to Mesenchymal Transition which either obstruct drivers of Primary Penile Squamous Cell Carcinoma and/or improve Cisplatin treatment effect.

3. What about Skullcap Supplements for Healthy Individuals with ASXL1 Mutation associated Genetic Risk?

Different companies offer panels of genes to be tested for assessing genetic risk to different cancers. These panels cover genes associated with cancers of the breast, ovary, uterus, prostate, and gastrointestinal system and others. Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant may also guide testing and diagnosis of at-risk relatives. ASXL1 is one of the genes generally available in panels for cancer risk testing.

ASXL1 mutation causes biochemical pathways/processes like Oncogenic Cancer Epigenetics and Suppressive Histone Methylation to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Skullcap should not be taken when the genetic panel identifies mutation of ASXL1 for Chronic Myelomonocytic Leukemia. Skullcap impacts pathways/processes like Oncogenic Cancer Epigenetics and creates adverse conditions with ASXL1.

4. What about Skullcap Supplements for Healthy Individuals with MLH1 Mutation associated Genetic Risk?

MLH1 is one of the genes available in panels for cancer risk testing. MLH1 mutation causes biochemical pathways/processes like Chromatin Remodeling and Mismatch Repair to get impacted. These pathways are direct or indirect drivers of cancer molecular endpoints. Skullcap supplements may be considered when the genetic panel identifies mutations in MLH1 for Colon Cancer. Skullcap impacts pathways/processes like Chromatin Remodeling and creates a canceling effect in those individuals with MLH1 mutation.

* Other Factors are also included like BMI, Treatments, Lifestyle Habits

In Conclusion

It is important to remember that cancer chemotherapy treatments and nutrition are never the same for everyone. Food and nutritional supplements like Skullcap are chosen by you and can influence outcomes.

“What should I eat?” is a commonly asked question by cancer patients and those at-risk. The answer to this question depends on cancer indication, underlying genetics, current chemotherapy treatments, food allergies, lifestyle information, and food preferences.

The addon.life approach to nutrition personalization uses knowledge of active ingredients contained in foods and nutritional supplements, cancer biology, chemotherapy treatment action and genetic mutation prevalence across cancer indications. addon.life team of clinicians, clinical scientists and engineers are experts in cancer biology focusing only on nutrition personalization for cancer patients and those at-risk.

What food you eat and which supplements you take is a decision you make. Your decision should include consideration of the cancer gene mutations, which cancer, ongoing treatments and supplements, any allergies, lifestyle information, weight, height and habits.

The nutrition planning for cancer from addon is not based on internet searches. It automates the decision making for you based on molecular science implemented by our scientists and software engineers. Irrespective of whether you care to understand the underlying biochemical molecular pathways or not - for nutrition planning for cancer that understanding is needed.

Get started NOW with your nutrition planning by answering questions on the name of cancer, genetic mutations, ongoing treatments and supplements, any allergies, habits, lifestyle, age group and gender.

References

• cBioPortal for Cancer Genomics
• Wogonin suppresses the LPS‑enhanced invasiveness of MDA‑MB‑231 breast cancer cells by inhibiting the 5‑LO/BLT2 cascade.
• Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
• Reversal of epigenetic aberrations associated with the acquisition of doxorubicin resistance restores drug sensitivity in breast cancer cells.
• cBioPortal for Cancer Genomics
• Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer.
• Cancer therapy shapes the fitness landscape of clonal hematopoiesis.